Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 601–700 of 1,000
Preconditioning Approach in Stem Cell Therapy for the Treatment of Infarcted Heart
Haider, K. H., & Ashraf, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00015-0 · Cited by 47
Scaffold-based tissue engineering approaches in treating infertility
Jahanbani, Y., Davaran, S., Ghahremani‐Nasab, M., Maleki, L. A., & Yousefi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117066 · Cited by 47
Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
Wagner, M. J., Khan, M., & Mohsin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00639 · Cited by 51
“CBSCs contain a paracrine secretome that is enriched in growth factors that have been reported to be cardioprotective (7, 207, 208).”
BackgroundGhanta, R. K., Aghlara-Fotovat, S., Pugazenthi, A., Ryan, C. T., Singh, V., Mathison, M. N., Jarvis, M., Mukherjee, S., Hernández, A., & Veiseh, O. (2020) · Biomaterials Science · doi:10.1039/d0bm00855a · Cited by 48
Xun, C., Ge, L., Tang, F. R., Wang, L., Zhuo, Y., Long, L., Qi, J., Hu, L., Duan, D., Chen, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110584 · Cited by 49
Dong, Q., Yang, Y., Song, L., Qian, H., & Xu, Z.-M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.08.047 · Cited by 47
“A substantial portion of the healing effects ofMSCs implantationwas attributable to save of endangered ischemicmyocardium [12].”
BackgroundDzau, V. J., Gnecchi, M., & Pachori, A. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.023 · Cited by 47
Self-citationThe therapeutic potential of MSC-EVs as a bioactive material for wound healing
Hou, Y., Li, J., Guan, S., & Witte, F. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2021.11.003 · Cited by 52
Sun, D., Mou, S., Chen, L., Yang, J., Wang, R., Zhong, A., Wang, W., Tong, J., Wang, Z., & Sun, J. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00325-y · Cited by 47
“A cell-free therapeutic technique was developed following the discovery that the conditioned medium obtained from gene-edited cells has cytoprotective properties [59].”
MethodWindmolders, S., Boeck, A. D., Koninckx, R., Daniëls, A., Wever, O. D., Bracke, M., Hendrikx, M., Hensen, K., & Rummens, J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.016 · Cited by 49
“Proposed mechanisms of action include the enhancement/ modulation of cytoprotection [13], neovascularization [14], contractility [15], fibrotic remodeling [16] and inflammatory processes [17].”
Very Small Embryonic-Like Stem Cells: Biology and Therapeutic Potential for Heart Repair
Zuba‐Surma, E. K., Wojakowski, W., Ratajczak, M. Z., & Dawn, B. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3817 · Cited by 51
“It has already been postulated that such ‘‘paracrine’’ effects may be predominantly responsible for the benefits observed with other stem/progenitor cells transplanted for heart repair (26).”
Stem cell-based therapy: Improving myocardial cell delivery
Feyen, D. A. M., Gaetani, R., Doevendans, P. A., & Sluijter, J. P. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.023 · Cited by 49
Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions
Wagner, T., Traxler, D., Simader, E., Beer, L., Narzt, M., Gruber, F., Madlener, S., Laggner, M., Erb, M., Vorstandlechner, V., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36928-6 · Cited by 41
Self-citationWelt, F. G. P., Gallegos, R. P., Connell, J., Kajstura, J., D’Amario, D., Kwong, R. Y. K., Coelho‐Filho, O. R., Shah, R. V., Mitchell, R. N., Leri, A., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.972273 · Cited by 45
“These collections of cells were identified in 2 animals that received control PBS injections only, and in 1 animal receiving mCSCs and vCSCs.”
BackgroundInfluentialBioengineering extracellular vesicles: smart nanomaterials for bone regeneration
Man, K., Eisenstein, N., Hoey, D. A., & Cox, S. C. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01895-2 · Cited by 48
“The intercellular communication via the delivery of these EV-associated bioactive factors is critical in mediating biological functions between cells [20, 21].”
BackgroundWANG, D.-G., Zhang, F., Chen, M., Zhu, H., Yang, B., & Cao, K. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1923 · Cited by 45
Bakondi, B., Shimada, I. S., Peterson, B. M., & Spees, J. L. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0198 · Cited by 49
Cardiac Cell-Based Therapy: Cell Types and Mechanisms of Actions
Ramos, G. A., & Hare, J. M. (2007) · Cell Transplantation · doi:10.3727/096368907783338208 · Cited by 45
“At the same time that feasibility and potential clinical dium (4,62).”
BackgroundWragg, A., Mellad, J. A., Beltran, L. E., Анатольевич, К. М., San, H., Boozer, S., Deans, R., Mathur, A., Lederman, R. J., Kovacic, J. C., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0390-7 · Cited by 45
“In keeping with other studies of BM derived cells [13,22,29-31], we demonstrated that MDPCs also secrete multiple cytokines in vitro that are known to modulate inflammatory and angiogenic processes.”
Enoki, C., Otani, H., Satoh, D., Okada, T., Hattori, R., & Imamura, H. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.04.012 · Cited by 45
Jameel, M. N., Li, Q., Mansoor, A., Xiong, Q., Sarver, A. L., Wang, X., Swingen, C., & Zhang, J. J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01100.2009 · Cited by 45
“myocardium at the time of acute MI (8, 9, 20).”
BackgroundLiu, J., van Mil, A., Aguor, E. N. E., Siddiqi, S., Vrijsen, K. R., Jaksani, S., Metz, C. H. G., Zhao, J., Strijkers, G. J., Doevendans, P. A., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01551.x · Cited by 45
Abo-Aziza, F. A. M., & Zaki, A. K. A. (2017) · PubMed Central · Cited by 65
Ho, C.-H., Lan, C.-W., Liao, C.-Y., Hung, S., Li, H., & Sung, Y. (2017) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.03.013 · Cited by 45
“Prior studies have demonstrated that cardiac transfer of MSCs could favorably repair infarcted myocardium and nearly normalize cardiac performance23; however, the fact that functional improvement was observed as early as within 72 h has raised the question as to whether such early effects could be attributed to the my…”
BackgroundZhao, M., Fan, C., Erñst, P., Tang, Y., Zhu, H., Mattapally, S., Oduk, Y., Borovjagin, A. V., Zhou, L., Zhang, J. J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy207 · Cited by 46
Extracellular Vesicles in Joint Disease and Therapy
Boere, J., Malda, J., van de Lest, C. H. A., van Weeren, P. R., & Wauben, M. H. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02575 · Cited by 45
“The supposed mechanism through paracrine signaling is supported by several studies showing that conditioned medium from MSCs alone (100, 101), or even only the culture medium EV-fraction (102), is sufficient to induce beneficial effects to harmed tissue or to prevent tissue damage.”
BackgroundCastiglione, M. A., Jiang, Y., Mazzeo, C., Lee, S., Chen, J., Kaushansky, K., Yin, W., Lin, R. Z., Zheng, H., & Zhan, H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15095 · Cited by 48
Erythropoietin expands a stromal cell population that can mediate renoprotection
Bi, B., Guo, J.-K., Marlier, A., Lin, S., & Cantley, L. G. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90218.2008 · Cited by 47
“Multiple studies have demonstrated that injury of heart, nerves, or kidney by either tissue ischemiareperfusion or toxin exposure can be prevented or diminished by the infusion of MSCs that have been expanded in vitro and reinfused in large numbers (1, 4, 11, 14, 20, 31, 33).”
BackgroundEzquer, M., Ezquer, F. E., Arango-Rodríguez, M. L., & Conget, P. A. (2012) · Biological Research · doi:10.4067/s0716-97602012000300010 · Cited by 47
Zhang, H., Huang, J., & Alahdal, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115715 · Cited by 45
Extracellular vesicle therapy in neurological disorders
Putthanbut, N., Lee, J.-Y., & Borlongan, C. V. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01075-w · Cited by 48
The role of progenitor cells in the development of intimal hyperplasia
Tsai, S. X., Butler, J. M., Rafii, S., Liu, B., & Kent, K. C. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.07.060 · Cited by 44
Apoptosis of Bone Marrow Mesenchymal Stem Cells Caused by Homocysteine via Activating JNK Signal
Cai, B., Li, X., Wang, Y., Liu, Y., Yang, F., Chen, H., Yin, K., Tan, X., Zhu, J., Pan, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063561 · Cited by 46
“Nevertheless, some pathological stimuli such as hypoxia, ischemia, inflammation or acidosis commonly led to the dysfunction or apoptosis of BMSCs, which servers as a new reason of cardiovascular conditions [9–11].”
BackgroundCardiovascular Disease in Young Women: A Population at Risk
Levit, R. D., Reynolds, H. R., & Hochman, J. S. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e31820987b5 · Cited by 50
“Smoking is the leading cause of preventable deaths, accounting for 450,000 annually, 35% to 40% of which were CVD related.(27) On an average, young smokers die 13 to 14 years earlier than nonsmokers.”
BackgroundMeng, X., Li, J., Yu, M., Yang, J. Z., Zheng, M., Zhang, J., Sun, C., Liang, H., & Liu, L. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25919 · Cited by 45
“…structural and functional healing of damaged myocardium by MSC may be greatly improved by simultaneous administration of potentiating compounds such as growth factors, anti-apoptotic agents or immunomodulators (Gnecchi et al., 2005; Hahn et al., 2008; Seropian, Toldo, Van Tassell, & Abbate, 2014).”
BackgroundConcise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke
Doeppner, T. R., Bähr, M., Hermann, D. M., & Giebel, B. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0081 · Cited by 44
Poynter, J. A., Herrmann, J. L., Manukyan, M. C., Wang, Y., Abarbanell, A. M., Weil, B. R., Brewster, B. D., & Meldrum, D. R. (2011) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.04.005 · Cited by 45
Li, X.-H., Zhou, X., Zeng, S., Ye, F., Yun, J.-L., Huang, T.-G., Li, H., & Li, Y. (2008) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282fc6165 · Cited by 44
TAN, G. M. Y., SHIM, W. S. N., Gu, Y., Qian, L., Chung, Y. Y., Lim, S. Y., Yong, P. J. A., Sim, E. K. W., & Wong, P. (2010) · Differentiation · doi:10.1016/j.diff.2010.02.005 · Cited by 44
Santhanam, A. V. R., Smith, L. A., He, T., Nath, K. A., & Katušić, Z. S. (2007) · Circulation Research · doi:10.1161/01.res.0000265848.55035.5d · Cited by 43
Tatsumi, K., Otani, H., Satoh, D., Enoki, C., Iwasaka, T., Imamura, H., Taniuchi, S., Kaneko, K., Adachi, Y., & Ikehara, S. (2008) · Circulation Journal · doi:10.1253/circj.72.1351 · Cited by 43
Extracellular vesicles: A new therapeutic strategy for joint conditions
Tofiño-Vian, M., Guillén, M. I., & Alcaraz, M. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.004 · Cited by 45
“the demonstration that MSCs act through paracrine effects in animal models of ischemic heart disease and acute kidney injury [75-79].”
BackgroundThe therapeutic application of mesenchymal stem cells at the ocular surface
Sahu, A., Foulsham, W., Amouzegar, A., Mittal, S. K., & Chauhan, S. K. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.01.006 · Cited by 45
“The therapeutic effects of MSCs have been emulated using MSC-conditioned medium, highlighting the importance of paracrine factors [26-29].”
Engineering Functional Cardiac Tissues for Regenerative Medicine Applications
Tomov, M. L., Gil, C. J., Cetnar, A. C., Theus, A. S., Lima, B., Nish, J., Bauser‐Heaton, H. D., & Serpooshan, V. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1178-9 · Cited by 45
Zhang, E., Geng, X., Shan, S., Li, P., Li, S., Li, W., Yu, M., Peng, C., Wang, S., Shao, H., et al. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1950250 · Cited by 44
“However, colonization of mesenchymal stem/stromal cells (MSCs) in the injury site is relatively few and MSCs therapy might be based less on in situ differentiation and more on paracrine or trophic factors (Gnecchi et al. 2005; Caplan and Dennis 2006).”
BackgroundVatsa, P., Negi, R., Ansari, U. A., Khanna, V., & Pant, A. B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02603-7 · Cited by 45
“Various studies suggested that secreted factors in the MSC secretome are to be held explicable for notable therapeutic influence in in vitro as well as in vivo conditions [38, 39] [40].”
BackgroundWinkler, T., von Roth, P., Schumann, M. R., Sieland, K., Stoltenburg, G., Taupitz, M., Perka, C., Duda, G. N., & Matziolis, G. (2008) · Tissue Engineering Part A · doi:10.1089/ten.tea.2007.0179 · Cited by 44
Flamant, S., Loinard, C., & Tamarat, R. (2023) · Environmental Advances · doi:10.1016/j.envadv.2023.100408 · Cited by 45
Hattori, Y., Kim, H., Tsuboi, N., Yamamoto, A., Akiyama, S., Shi, Y., Katsuno, T., Kosugi, T., Ueda, M., Matsuo, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140121 · Cited by 44
Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells
Gude, N. A., Joyo, E., Toko, H., Quijada, P. J., Villanueva, M., Hariharan, N., Sacchi, V., Truffa, S., Joyo, A. Y., Völkers, M., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0488-3 · Cited by 42
“Paracrine survival signals contribute to protective effects following adoptive transfer of various progenitor cell types into damaged myocardium [16, 17, 25, 29, 47, 48].”
Sustained IGF-1 Secretion by Adipose-Derived Stem Cells Improves Infarcted Heart Function
Bagno, L., de Carvalho, D. R., Mesquita, F., Louzada, R. A. N., de Andrade, B. S. C., Kasai-Brunswick, T. H., Lago, V. M., Suhett, G., Cipitelli, D., Werneck‐de‐Castro, J. P., et al. (2016) · Cell Transplantation · doi:10.3727/096368915x690215 · Cited by 45
Mesenchymal stem cells and their relationship to pericytes
Meirelles, L. D. S., Bellagamba, B. C., Camassola, M., & Nardi, N. B. (2015) · Frontiers in bioscience · doi:10.2741/4380 · Cited by 44
“In the mid-2000s, after a number of reports on the use of MSCs to treat various conditions in experimental animal models, some reports indicated the beneficial effects of MSC treatment were not attributable to differentiation, but to soluble molecules through paracrine action (76-79).”
BackgroundCritical View on Mesenchymal Stromal Cells in Regenerative Medicine
Langrzyk, A., Nowak, W. N., Stępniewski, J., Jaźwa, A., Florczyk, U., Józkowicz, A., & Dulak, J. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7159 · Cited by 45
“…studies performed by the same group confirmed that the paracrine activity of Akt1-MSC is responsible for the observed improvement of heart function (67) and specifically revealed that secreted frizzled-related protein 2 (Sfrp2) was the key factor that mediated myocardial survival and repair after…”
Dolati, S., Yousefi, M., Mahdipour, M., Rad, A. A., Pishgahi, A., Nouri, M., & Jodati, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27531 · Cited by 43
“The cardioprotective consequence of MSCs were related to overexpression of Akt‐1 (protein kinase B).(70) Akt‐MSCs discharge secreted frizzled related protein 2 protein, which poses prosurvival consequences besides its role of regulating Wnt signaling.”
BackgroundMesenchymal Stem Cells for Cardiac Regeneration: from Differentiation to Cell Delivery
Gupta, S., Sharma, A., Archana, S. S., & Verma, R. S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10168-0 · Cited by 47
“Currently, the strong paracrine capacity of MSCs has been implicated as the principal mechanism for the therapeutic modality in cardiovascular diseases, although at least in part is mediated by MSCs stimulation of resident cardiac stem cells and fusion of MSCs with cardiomyocytes (CMCs) leading to the replacement of l…”
BackgroundZhou, Y., Zhou, J., Xu, X., Du, F., Nie, M., Hu, L., Ma, Y., Liu, M., Yu, S., Zhang, J., et al. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0005 · Cited by 42
Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering
Charbe, N. B., Tambuwala, M. M., Palakurthi, S. S., Warokar, A., Hromić‐Jahjefendić, A., Bakshi, H. A., Zacconi, F. C. M., Mishra, V. K., Khadse, S. C., Aljabali, A. A. A., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10333 · Cited by 47
“involves the paracrine secretion of cytoprotective agents from the adult bone marrow-derived stem cells.(202) Lai et al.”
BackgroundLi, Z., Hua, W., Deng, L., Cong, X., & Chen, X. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07770.x · Cited by 44
Cai, B., Meng, F., Zhu, S., Zhao, J., Liu, J., Liu, C., Chen, N., Ye, M.-L., Li, Z., Ai, J., et al. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.01.001 · Cited by 42
Lim, J., Jang, J.-B., Kim, J., Moon, S., Lee, C.-N., & Lee, K.-J. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.5.663 · Cited by 42
“Instead, the injected cells might rather stimulate the intrinsic stem cells in a paracrine way to help them proliferate and differentiate (27).”
BackgroundYao, Y., Huang, C. Y., Gu, P., & Wen, T. (2016) · Cell Transplantation · doi:10.3727/096368915x689938 · Cited by 42
“(8,18,22,23,30,33); MSC-derived CM, which contained multiple secreted factors, has a protective effect in promoting cell survival and migration (21).”
BackgroundLee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 45
Hyaluronan Enhances Bone Marrow Cell Therapy for Myocardial Repair After Infarction
Chen, C.-H., Wang, S., Wei, E. I. H., Chu, T., & Hsieh, P. C. H. (2013) · Molecular Therapy · doi:10.1038/mt.2012.268 · Cited by 41
Jenkins, N. T., Martin, J. S., Laughlin, M. H., & Padilla, J. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0241-5 · Cited by 44
“This blood vessel-mediated skeletal muscle angiogenesis is a welldocumented phenomenon [176], and in fact the prevailing evidence indicates that most CAC types probably do not incorporate into growing vasculature, but exert their proangiogenic effects through paracrine mechanisms [177, 178].”
BackgroundThe Paracrine Effect: Pivotal Mechanism in Cell-Based Cardiac Repair
Maltais, S., Tremblay, J. P., Perrault, L. P., & Ly, H. Q. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9198-2 · Cited by 45
“Based on these prosurvival effects related to Akt secretion, Gnecchi and colleagues went a step further by overexpressing Akt on the surface of MSC in a series of seminal studies on the importance of paracrine factors in cardiac repair [57–60].”
BackgroundConnexin43 promotes survival of mesenchymal stem cells in ischaemic heart
Wang, D., Shen, W., Zhang, F., Chen, M., Chen, H., & Cao, K. (2010) · Cell Biology International · doi:10.1042/cbi20090118 · Cited by 41
He, J., Wang, C., Sun, Y., Lu, B., Cui, J., Dong, N., Zhang, M., LIU, Y., & Yu, B. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2509 · Cited by 41
“Several clinical trials have highlighted the therapeutic effects of MSC transplantation, by reducing the size of the infarct area and improving the left ventricular ejection fraction (2,3).”
Chung, S., Rho, S., Kim, G.-J., Kim, S., Baek, K., Kang, M.-S., & Lew, H. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2532 · Cited by 42
“A previous study focused on the direct mechanisms of CP-MSC therapeutic effectiveness, as well as on an indirect paracrine mechanism (40,49).”
Stretchable ECM Patch Enhances Stem Cell Delivery for Post‐MI Cardiovascular Repair
Kim, I. G., Hwang, M. P., Park, J. S., Kim, S., Kim, J., Kang, H. J., Subbiah, R., Ko, U. H., Shin, J. H., Kim, C., et al. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900593 · Cited by 42
Towards Reaching the Target: Clinical Application of Mesenchymal Stem Cells for Diabetic Foot Ulcers
Dash, S. N., Dash, N. R., Guru, B., & Mohapatra, P. C. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1467 · Cited by 41
“55 Table 3 presents published results that have been proved effective in clinical practice for non-healing ulcers, including our previous experiment.”
Lactate modulates gene expression in human mesenchymal stem cells
Zieker, D., Schäfer, R., Glatzle, J., Nieselt, K., Coerper, S., Kluba, T., Northoff, H., Königsrainer, A., Hunt, T., & Beckert, S. (2008) · Langenbeck's archives of surgery (Print) · doi:10.1007/s00423-008-0286-6 · Cited by 33
“The paracrine mode of action has been popularised by studies in which MSC-conditioned media injected into myocardial infarct sites resulted in decreased infarct areas and less apoptotic cells [21, 22].”
Cardiovascular Magnetic Resonance Imaging in Experimental Models
Price, A., Cheung, K., Cleary, J., Campbell, A., Riegler, J., & Lythgoe, M. (2010) · Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010278 · Cited by 46
“Following this hypothesis many studies in animals [104-112] and a few clinical trials [112-114] have been conducted.”
BackgroundAbarbanell, A. M., Wang, Y., Herrmann, J. L., Weil, B. R., Poynter, J. A., Manukyan, M. C., & Meldrum, D. R. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01087.2009 · Cited by 41
Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy
Cai, B., Tan, X., Zhang, Y., Li, X., Wang, X., Zhu, J., Wang, Y., Yang, F., Wang, B., Liu, Y., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0032 · Cited by 41
Jolicoeur, M. E., Granger, C. B., Fakunding, J. L., Mockrin, S. C., Grant, S. M., Ellis, S. G., Weisel, R. D., & Goodell, M. A. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.02.028 · Cited by 41
Considerations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction
Sharma, P., Wang, X., Ming, C. L. C., Vettori, L., Figtree, G. A., Boyle, A., & Gentile, C. (2021) · Small · doi:10.1002/smll.202003765 · Cited by 43
Yamada, Y., Minatoguchi, S., Kanamori, H., Mikami, A., Okura, H., Dezawa, M., & Minatoguchi, S. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.10.030 · Cited by 41
Mesenchymal Stem Cell-Derived Exosomal microRNAs in Cardiac Regeneration
Bhaskara, M. C., Anjorin, O., & Wang, M. (2023) · Cells · doi:10.3390/cells12242815 · Cited by 40
Sultana, P., Kim, Y. K., Cho, S. J., Asadujjaman, M., & Jee, J. (2025) · Biomaterials Science · doi:10.1039/d5bm00660k · Cited by 44
Ovarian rescue in women with premature ovarian insufficiency: facts and fiction
Pellicer, N., Cozzolino, M., Díaz‐García, C., Galliano, D., Cobo, A. C., Pellicer, A., & Herraiz, S. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.12.011 · Cited by 42
Höetzenecker, K., Assinger, A., Lichtenauer, M., Mildner, M., Schweiger, T., Starlinger, P. P., András, J., Berényi, E. L., Pávó, N., Zimmermann, M., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0292-2 · Cited by 40
“Recently, this concept was challenged by works showing that paracrine signalling may be a significant additional mode of action [19, 41, 52, 53].”
BackgroundResult“AKT”ing Lessons for Stem Cells: Regulation of Cardiac Myocyte and Progenitor Cell Proliferation
Sussman, M. A. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.08.003 · Cited by 40
“Cardioprotection is enhanced by induction of AKT in adoptive transfer of either bone marrow stem cells exposed to hypoxia (Uemura et al. 2006) or mesenchymal stem cells genetically modified to constitutively express activated AKT (Gnecchi et al. 2005) in the infarcted heart.”
BackgroundTracking Fusion of Human Mesenchymal Stem Cells After Transplantation to the Heart
Freeman, B. T., Kouris, N. A., & Ogle, B. M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0198 · Cited by 41
Optimizing Stem Cell Function for the Treatment of Ischemic Heart Disease
Herrmann, J. L., Abarbanell, A. M., Weil, B. R., Manukyan, M. C., Poynter, J. A., Brewster, B. D., Wang, Y., & Meldrum, D. R. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.05.057 · Cited by 40
“This hypothesis is further supported by the observation that delivery of cell-free conditioned media from MSCs conferred cardioprotection during ischemia [15, 18, 19].”
Baral, H., Uchiyama, A., Yokoyama, Y., Sekiguchi, A., Yamazaki, S., Amalia, S. N., Inoue, Y., Ogino, S., Torii, R., Hosoi, M., et al. (2021) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2021.08.006 · Cited by 40
Bonacchi, M., Nistri, S., Nanni, C., Gelsomino, S., Pini, A., Cinci, L., Maiani, M., Zecchi‐Orlandini, S., Lorusso, R., Fanti, S., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00503.x · Cited by 39
“This is consistent with the recent ‘paracrine’ hypothesis to explain the functional benefits of stem cell therapy in the post-infarcted, dysfunctional heart [14, 15, 33, 34, 40].”
Nordlie, M. A., Wold, L. E., Simkhovich, B. Z., Sesti, C., & Kloner, R. A. (2006) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840601100102 · Cited by 40
“For example, Gnecchi et al (80) recently demonstrated that soluble factors produced by mesenchymal stem cells into which the antiapoptotic gene Akt1 had been transferred had a protective effect on cardiomyocytes under ischemic conditions both in vitro and in vivo.”
BackgroundStem Cells Are Not Proarrhythmic: Letting the Genie out of the Bottle
Ly, H. Q., & Nattel, S. (2009) · Circulation · doi:10.1161/circulationaha.108.812701 · Cited by 39
Xu, L., Wang, Q., Xu, F., Ye, Z., Zhou, Y., & Tan, W. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0605 · Cited by 38
Cardiac Repair with Adult Bone Marrow-Derived Cells: The Clinical Evidence
Dawn, B., Abdel‐Latif, A., Sanganalmath, S. K., Flaherty, M. P., & Zuba‐Surma, E. K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2462 · Cited by 38
“Other potential mechanisms via which BMC therapy may reduce scar size include salvage of native cardiomyocytes (30, 47) or generation of new myocytes via the activation of tissue-resident cardiac progenitors (12, 20).”
Xu, B., Luo, Y., Liu, Y., Li, B., & Wang, Y. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00737.2014 · Cited by 39
Faezi, M., Maleki, S. N., Aboutaleb, N., & Nikougoftar, M. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.08.004 · Cited by 38
Exosomes: Cell-Free Therapy for Cardiovascular Diseases
He, N., Zhang, Y., Zhang, S., Wang, D., & Ye, H. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-09966-7 · Cited by 38
Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy
Sun, H., Pratt, R. E., Hodgkinson, C. P., & Dzau, V. J. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00516.2019 · Cited by 41
Self-citationde Oliveira, N. C., Neri, E. A., da Silva, C. M., Valadão, I. C., Fonseca‐Alaniz, M. H., Zogbi, C., Levy, D., Bydlowski, S. P., & Krieger, J. E. (2022) · Clinical Science · doi:10.1042/cs20220216 · Cited by 39
Heidari, N., Abbasi‐Kenarsari, H., Namaki, S., Baghaei, K., Zali, M. R., Mirsanei, Z., & Hashemi, S. M. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113296 · Cited by 42
Csöbönyeiová, M., Beerová, N., Klein, M., Čeháková, M., & Danišovič, Ľ. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810314 · Cited by 41
Tieu, A., Stewart, D. J., Chwastek, D., Lansdell, C., Burger, D. E., & Lalu, M. M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03472-8 · Cited by 40
Saraswati, S., Guo, Y. P., Atkinson, J. B., & Young, P. P. (2014) · Stem Cells · doi:10.1002/stem.1935 · Cited by 38
Herrmann, J. L., Weil, B. R., Abarbanell, A. M., Wang, Y., Poynter, J. A., Manukyan, M. C., & Meldrum, D. R. (2011) · Shock · doi:10.1097/shk.0b013e31820b2fb9 · Cited by 43
“One mechanism of stem cellYmediated cardioprotection is the paracrine secretion of growth factors (8).”
Background
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.